Sappi: corporate overview

January 2010

2

3 Fine Paper mills5 Forest Products mills10 Sales offices

1 Sales office

9 Fine Paper mills17 Sales offices

1 Fine Paper mill JV4 Sales offices

1 Sales office

2 Fine Paper mills1 Specialty Paper mill5 Sales offices

1 Sales office

1 Sales office

Group overview

3

We are the world’s leading producer of high quality coated fine paper used in printing everything from art books to quality magazines to wine labels. (USA, Europe, South Africa, China JV)

We also produce a range of business paper, coated and uncoated speciality paper and casting release paper. (USA, Europe, SA)

We are the largest and lowest cost producer of the chemical cellulose pulp used to produce viscose fiber. (SA – 100% export)

We manufacture on four continents and have 40 sales offices around the globe, supplying paper and pulp to customers in over 100 countries.

We employ over 15,600 people and achieved an annual turnover of US$5.369 million (2009)

We are listed on the stock exchanges of Johannesburg and New York.

Sappi Limited - who are we today?

4

Fine paper mills in South Africa

Enstra Mill

200,000 tonsuncoated fine paper105,000 tons pulp

Stanger Mill110,000 tons

coated fine paper and tissue

60,000 tons pulp

Adamas Mill

40,000 tons uncoated fine paper

Total fine paper capacity in SA: 350,000 tons/year

5

Forest Product operations in Southern Africa

Plantations in Mpumalanga, Kwa Zulu Natal and Swaziland:

527,000ha land - 380,000ha planted

Cape Kraft 60,000 tons kraft

510,000 tons pulp 240,000 tons kraft

140,000 tons newsprint

Ngodwana

800,000 tons chemical cellulose (dissolving pulp)

Saiccor390,000 tons kraft 350,000 tons pulp

Tugela

6

Corporate Social Responsibility: community development

Various projects: Braamfontein rejuvenation

Refurbished Sappi Head Office and Piazza

7

TB in Sappi

38

9792

115

79

60

78

176

16

0

20

40

60

80

100

120

140

160

180

2002 2003 2004 2005 2006 2007 2008 2009 2010

Number of TB cases treated at the Sappi clinics

8

Disease profile of the 3 funds from 01/10/00 - 31/6/07

19%

8%

0%

4%

29%

2%

5% 4%

11%

17%

12%

4%6%

2% 3% 3%

57%

0%

4%

7%

9%

2%

8%

0%

15%

2% 2%4%

48%

1%

3%

6% 6%

3%

9%

2%0%

10%

20%

30%

40%

50%

60%

Neuro Ca Vision Pulm. AIDS Psychotic Back Diabetes Orthopedic Depression Cardio Renal

Pension PPAWUW Provident

9

Sappi Manage TB

Centre of excellence:

Sappi Sister obtain the sputum sample

Sappi Sister submit sample to the DoH lab

Sappi Sister receive the results within 3-4 days

DoH liaise with Sappi sister regarding treatment

Sappi Sister initiate DOT and monitor the patient for duration of treatment.

Partnership between Sappi and DoH

10

Situation in most of the Units:

Patient refer to local clinic with long waiting lists – loose a day of work

Wait 1-2-3 weeks for results – numerous phone calls, staff turnover

Patient to clinic where treatment is initiated – little to no communication with DoH

DOT: Never sure what DoH has implemented - Sappi implement another system. Cause confusion.

Repeat medication collection: patient loose each time a day from work.

Sputum results: Again communication breakdown

11

Action required:

Sappi to initiate partnership with DoH.

Training of health personnel

Re-launch TB awareness programmes

Implement DOT

TB testing cumbersome and time consuming

Clinics safer places

12

13

14

www.sappi.com